Andhra CM requests PM Modi to allow sharing of Covaxin manufacturing tech

Jagan Mohan Reddy claimed that the present total manufacturing capacity of Covaxin did not cater to the country's requirement

Covaxin
Covaxin (Photo: Bloomberg)
Press Trust of India Amaravati
2 min read Last Updated : May 11 2021 | 6:49 PM IST

Y S Jagan Mohan Reddy on Tuesday asked the Centre to direct Bharat Biotech and ICMR-NIV to transfer the Covaxin manufacturing technology and provide the viral strain to "whoever is interested and capable of manufacturing the vaccine" so that the production could be ramped up.

In a letter to Prime Minister Narendra Modi, Jagan claimed that the present total manufacturing capacity of Covaxin did not cater to the country's requirement.

"It may take several months to get all vaccinated at this pace. Please explore the possibility of involving all such production firms and enable them with the technology, intellectual property rights to deliver the vaccine as quickly and as affordable as possible," the Chief Minister said.

"Anyone who can manufacture or is interested in manufacturing the vaccine should be encouraged to do so in the larger public interest.Entire manufacturing capacity should be mobilised and put to use in this testing times," Jagan added.

He said the Prime Minister's intervention on these suggestions, and if implemented, would go a long way in encouraging the manufacturers and accelerate the supply of vaccines.

The Chief Minister said "we are not able to vaccinate our population at large" due to short supply of vaccine though the state demonstrated its capacity to inoculate six lakh people per day.

"I look forward to your favourable orders in this matter," Jagan told the Prime Minister.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Andhra Pradesh governmentCoronavirus Vaccine

First Published: May 11 2021 | 6:34 PM IST

Next Story